Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita

British Journal of Haematology

Volumn 92, Issue 3, 1996, Pages 758-765

  Langston, Amelia A ^a   Sanders, Jean E ^a   Deeg, H Joachim ^a   Crawford, Stephen W ^a   Anasetti, Claudio ^a   Sullivan, Keith M ^a   Flowers, Mary E D ^a   Storb, Rainer ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Aplastic anaemia; Bone marrow transplantation; Dyskeratosis congenita; Opportunistic infection; Pulmonary fibrosis

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; THYMOCYTE ANTIBODY;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CHILD; CLINICAL ARTICLE; DYSKERATOSIS CONGENITA; FEMALE; GRAFT REJECTION; HUMAN; HUMAN CELL; LUNG FIBROSIS; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; WHOLE BODY RADIATION;

EID: 0029967609     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.424984.x     Document Type: Article

References (48)

1. Berthou, C., Devergie, A., D'Agay, M.F., Sonsino, E., Scrobohaci, M.L., Loirat, C. & Gluckman, E. (1991) Late vascular complications after bone marrow transplantation for dyskeratosis congenita. British Journal of Haematology, 79, 335-336.
2. Camitta, B.M., Thomas, E.D., Nathan, D.G., Gale, R.P., Kopecky, K.J., Rappeport, J.M., Gordon-Smith, E.C. & Storb, R. (1979) A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood , 53, 504-514.
3. Chessells, J.M. & Harper, J. (1992) Bone marrow transplantation for dyskeralosis congenita. British Journal of Haematology, 81, 314.
4. Cole, H.N., Rauschkolb, J.E. & Toomey, J. (1930) Dyskeratosis congenita with pigmentation, dystrophy unguis and leukokeratosis oris. Archives of Dermatology and Syphilology, 21, 71-95.
5. Connor, J.M., Gatherer, D., Gray, F.C., Pirrit, L.A. & Affara, N.A. (1986) Assignment of the gene for dyskeratosis congenita to Xq28. Human Genetics, 72, 348-351.
6. Connor, J.M. & Teague, R.H. (1981) Dyskeratosis congenita: report of a large kindred. British Journal of Dermatology, 105, 321-325.
7. Conter, V., Johnson, F.L., Paolucci, P., Ruggiero, M. & Janco, R.L. (1988) Bone marrow transplantation for aplastic anemia associated with dyskeratosis congenita. American Journal of Pediatric Hematology-Oncology, 10, 99-102.
8. Crawford, S.W., Longton, G. & Storb, R. (1995) Acute graft-versus-host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anaemia. Bone Marrow Transplantation, 12, 225-231.
9. DeBauch, D.M., Pai, G.S. & Stanley, W.S. (1990) Enhanced G2 chromatid radiosensitivity in dyskeratosis congenita fibroblasts. American Journal of Human Genetics , 46, 350-357.
10. Deeg, H.J., Storb, R., Thomas, E.D., Appelbaum, F., Buckner, C.D., Clift, R.A., Doney, K., Johnson, L., Sanders, J.E., Stewart, P., Sullivan, K.M. & Witherspoon, R.P. (1983) Fanconi's anemia treated by allogeneic marrow transplantation. Blood, 61, 954-959.
11. Dokal, I., Bungey, J., Williamson, P., Oscier, D., Hows, J. & Luzzatto, L. (1992) Dyskeratosis congenita libroblasts are abnormal and have unbalanced chromosomal rearrangements. Blood, 80, 3090-3096.
12. Drachtman, R.A. & Alter, B.P. (1992) Dyskeratosis congenita: clinical and genetic heterogeneity: report of a case and review of the literature. American Journal of Pediatric Hemalology-Oncology , 14, 297-304.
13. Engmann, M.F. (1935) Congenital atrophy of the skin with reticular pigmentation. Journal of the American Medical Association, 103, 1252-1256.
14. Feinberg, A.P. & Coffey, D.S. (1982) Organ site specificity for cancer in chromosomal instability disorders. Cancer Research, 42, 3252-3254.
15. Flowers, M.E., Doney, K.C., Storb, R., Deeg, H.J., Sanders, J.E., Sullivan, K.M., Bryant, E., Witherspoon, R.P., Appelbaum, F.R., Buckner, C.D., Hansen, J.A. & Thomas, E.D. (1992) Marrow transplantation for Fanconi anaemia with or without leukemic transformation: an update of the Seattle experience. Bone Marrow Transplantation, 9, 167-173.
16. Friedland, M., Lutoon, J.D., Spitzer, R. & Levere, R.D. (1985) Dyskeratosis congenita with hypoplastic anemia: a stem cell defect. American Journal of Hematology, 20, 85-87.
17. Giannetti, A. & Seidenari, S. (1980) Deficit of cell-mediated immunity, chromosomal alterations and defective DNA repair in a case of dyskeratosis congenita. Dermatologica, 160, 113-117.
18. Gluckman, E., Devergie, A., Schaison, G., Bussel, A., Berger, H., Sohier, J. & Bernard, J. (1980) Bone marrow transplantation in Fanconi anaemia. British Journal of Haematology, 45, 557-564.
19. Imokawa, S., Sato, A., Toyoshima, M., Yoshitomi, A., Tamura, R., Suda, T., Suganuma, H., Yagi, T., Iwata, M., Hayakawa, H. & Chida, K. (1994) Dyskeratosis congenita showing usual interstitial pneumonia. Internal Medicine, 33, 226-230.
20. Inoue, S., Mekanik, G., Mahallati, M. & Zuelzer, W.W. (1973) Dyskeratosis congenita with pancytopenia: another constitutional anemia. American Journal of Diseases of Children, 126, 389-396.
21. Kano, Y. & Fujiwara, Y. (1982) Dyskeratosis congenita: survival, sister chromatid exchange and repair following treatments with crosslinking agents. Mutation Research, 103, 327-332.
22. Lee, H.P., Yap, H.K., Quah, T.C., Chong, A. & Seah, C.C. (1992) T-cell immunodeficiency in dyskeratosis congenita. Archives of Diseases of Children, 67, 524-526.
23. Ling, N.S., Fenske, N.A., Julius, R.L., Espinoza, C.G. & Drake, L.A. (1985) Dyskeratosis congenita in a girl simulating chronic graft-vs-host disease. Archives of Dermatology, 121, 1424-1428.
24. Marsh, J.C.W., Will, A.J., Hows, J.M., Sartori, P., Darbyshire, P.J., Williamson, P.J., Oscier, D.G., Dexter, M. & Testa, N.G. (1992) 'Stem cell' origin of the hematopoietic defect in dyskeratosis congenita. Blood, 12, 3138-3144.
25. Mahmoud, H.K., Schaefer, U.W., Schmidt, C.G., Becher, R., Gotz, G.F. & Richter, H.J. (1985) Marrow transplantation for pancytopenia in dyskeratosis congenita. Blut, 51, 57-60.
26. Ning, Y., Yongshan, Y., Pai, G. & Gross, A.J. (1992) Heterozygote detection through bleomycin-induced G2 chromatid breakage in dyskeratosis congenita families. Cancer Genetics and Cytogenetics, 60, 31-34.
27. Pai, G.S., Morgan, S. & Whetsell, C. (1989a) Etiologic heterogeneity in dyskeralosis congenita. American Journal of Medical Genetics, 32, 63-66.
28. Pai, G.S., Yan, Y., DeBauch, D.M., Stanley, W.S. & Paul, S.R. (1989b) Bleomycin hypersensitivity in dyskeratosis congenita fibroblasts, lymphocytes, and transformed lymphoblasts. Cytogenetics and Cell Genetics, 52, 186-189.
29. Paul, S.R., Perez-Atayde, A. & Williams, D.A. (1992) Interstitial pulmonary disease associated with dyskeratosis congenita. American Journal of Pediatric Hematology-Oncology, 14, 89-92.
30. Petersdorf, E.W. & Deeg, H.J. (1992) Diagnostic use of molecular probes before and after marrow transplantation. Clinics in Laboratory Medicine, 12, 113-128.
31. Putterman, C., Safadi, R., Zlotogora, J., Banura, R. & Eldor, A. (1993) Treatment of the hematological manifestations of dyskeratosis congenita. Annals of Hematology, 66, 209-212.
32. Rose, C. & Kern, W.V. (1992) Another case of Pneumocystis carinii pneumonia in a patient with dyskeratosis congenita (Zinsser-Cole-Engman syndrome). Clinical Infectious Diseases, 15, 1056-1057.
33. Russo, C.L., Glader, B.E., Israel, R.J. & Galasso, F. (1990) Treatment of neutropenia associated with dyskeratosis congenita with granulocyte-macrophage colony-stimulating factor. Lancet, 336, 751-752.
34. Sanders, J.E., Storb, R., Anasetti, C., Deeg, H.J., Doney, K., Sullivan, K.M., Witherspoon, R.P. & Hansen, J. (1994) Marrow transplant experience for children with severe aplastic anemia. American Journal of Pediatric Hematology-Oncology, 16, 43-49.
35. Schneider, A., Mayer, U., Gebhart, E., Harma, D., Gromball, J., Glockel, U. & Beck, J.D. (1988) Clastogen-induced fragility may differentiate pancytopenia of congenital dyskeratosis from Fanconi anemia. European Journal of Pediatrics, 148, 37-39.
36. Sirinavin, C. & Trowbridge, A.A. (1975) Dyskeratosis congenita: clincal features and genetic aspects. Journal of Medical Genetics, 12, 339-354.
37. Smith, C.M., II, Ramsay, N.K.C., Branda, R., Nesbit, M.E. & Krivit, W. (1979) Response to androgens in the constitutional aplastic anemia of dyskeratosis congenita (DC). Pediatric Research, 13, 441.
38. Storb, R. (1993) Bone marrow transplantation for aplastic anemia. Cell Transplantation, 2, 365-379.
39. Storb, R., Deeg, H.J., Farwell, V., Doney, K., Appelbaum F., Beatty, P., Bensinger, W., Buckener, C.D., Clift, R., Hansen, J., Hill, R., Longton, G., Lum, L., Martin, P., McGuffin, R., Sanders, J., Singer, J., Stewart, P., Sullivan, K., Witherspoon, R. & Thomas, E.D. (1986) Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood, 68, 119-125.
40. Storb, R., Etzioni, R., Anasetti, C., Appelbaum, F.R., Buckner, C.D., Bensinger, W., Bryant, E., Clift, R., Deeg, H.J., Doney, K., Flowers, M., Hansen, J., Martin, P., Pepe, M., Sale, G., Sanders, J., Singer, J., Sullivan, K.M., Thomas, E.D. & Witherspoon, R.P. (1994) Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood , 84, 941-949.
41. Storb, R., Thomas, E.D., Buckner, C.D., Clift, R.A., Deeg, H.J., Fefer, A., Goodell, B.W., Sale, G.E., Sanders, J.E., Singer, J., Stewart, P. & Weiden, P.L. (1980) Marrow transplantation in thirty 'untransfused' patients with severe aplastic anemia. Annals of Internal Medicine, 92, 30-36.
42. Sullivan, K.M., Shulman, H.M., Storb, R., Weiden, P.L., Witherspoon, R.P., McDonald, G.B., Schubert, M.M., Atkinson, K. & Thomas, E.D. (1981) Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood, 57, 267-276.
43. Thomas, E.D., Storb, R., Clift, R.A., Fefer, A., Johnson, F.L., Neiman, P.E., Lerner, K.G., Glucksberg, H. & Buckner, C.D. (1975) Bone marrow transplantation. New England Journal of Medicine, 292, 832-843, 895-902.
44. Trowbridge, A.A., Sirinavin, C. & Linman, J.W. (1977) Dyskeratosis congenita: hematologic evaluation of a sibship and review of the literature. American Journal of Hematology, 3, 143-152.
45. Verra, F., Kouzan, S., Saiag, P., Bignon, J. & deCremoux, H. (1992) Bronchoalveolar disease in dyskeratosis congenita. European Respiratory Journal, 5, 497-499.
46. Wiedemann, H.P., McGuire, J., Dwyer, J.M., Sabetta, J., Gee, J.B., Smith, G.J. & Loke, J. (1984) Progressive immune failure in dyskeratosis congenita: report of an adult in whom Pneumocystis carinii and fatal disseminated candidiasis developed. Archives of Internal Medicine, 144, 397-399.
47. Yabe, M., Yabe, H., Matsuda, M., Hinohara, T., Oh, Y., Hattori, K., Ishikawa, K., Oshima, T., Yamamoto, H. & Kato, S. (1993) Bone marrow transplantation for Fanconi anaemia: adjustment of the dose of cyclophosphamide for preconditioning. American Journal of Pediatric Hematology-Oncology, 15, 377-382.
48. Zinsser, F. (1910) Atrophic cutis reticuloris cum pigmentation dystrophia unquim et leukoplakia oris. Ikonographia Dermatologica (Hyoto), 5, 219-223.